Why is Oxygenta Pharma falling/rising?

As of 06-Nov, Oxygenta Pharmaceutical Ltd's stock price is currently at 67.44, reflecting an increase of 1.23 or 1.86%. The stock has shown a strong performance today, having gained 9.16% over the past week and outperforming its sector by 2.63%. It opened with a significant gain of 4.03% and reached an intraday high of Rs 68.88. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 172.64% against the 5-day average. However, the stock's year-to-date performance remains negative at -22.90%, indicating challenges over a longer period, despite its impressive 3-year and 5-year returns of +145.24% and +823.84%, respectively. The positive factors contributing to the stock's recent rise include increased trading volume and consecutive gains over the last four days, while the absence of specific positive or negative dashboard factors limits a comprehensive analysis of other influences.
Broader market context reveals that Oxygenta's short-term performance has significantly outpaced the benchmark, with a 9.16% gain over the past week compared to a -1.30% decline in the Sensex. This contrast highlights the stock's resilience in the face of broader market challenges. However, the stock's longer-term performance remains under pressure, as indicated by its -3.24% return over the past month and -22.90% year-to-date, while the Sensex has shown a positive return of +6.62% year-to-date. This divergence suggests that while Oxygenta is currently experiencing a positive momentum, it faces ongoing challenges that could affect its performance in the longer term.